Rigel Pharmaceuticals (RIGL) Other Working Capital Changes (2010 - 2026)

Rigel Pharmaceuticals' Other Working Capital Changes history runs 17 years deep, the most recent figure standing at -$145000.0 for Q1 2026.

• In Q1 2026, Other Working Capital Changes fell 114.01% year-over-year to -$145000.0; the TTM figure through Mar 2026 stood at $10.7 million (up 1987.67% YoY), while the FY2025 annual figure was $11.8 million, up 1812.14% from the prior year.
• Other Working Capital Changes was -$145000.0 for Q1 2026 at Rigel Pharmaceuticals, down from $11.0 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $11.0 million in Q4 2025 to a low of -$5.7 million in Q3 2025.
• Historically, Other Working Capital Changes has averaged $557058.8 across 5 years, with a median of -$145000.0 in 2026.
• The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes soared 1771.78% in 2023, then sank 510.03% in 2025.
• A 5-year view of Other Working Capital Changes shows it stood at $1.8 million in 2022, then plunged by 215.38% to -$2.0 million in 2023, then plunged by 104.71% to -$4.2 million in 2024, then surged by 363.0% to $11.0 million in 2025, then sank by 101.32% to -$145000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$145000.0 (Q1 2026), $11.0 million (Q4 2025), and -$5.7 million (Q3 2025), per Business Quant data.